ANDA 88189, held by West Ward. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 88189 (Reserpine And Hydrochlorothiazide-50), held by West Ward, was first approved by FDA on May 10, 1984, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 10, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Reserpine And Hydrochlorothiazide-5050MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters